Adults aged 50 years and older demonstrate strong, durable immune responses after receiving an additional dose of the recombinant zoster vaccine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results